-transparent.png){kind=logo}
In order to assess the mechanisms of proopiomelanocortin (POMC) gene expression in human ACTH-producing tumors, we performed the simultaneous evaluation of POMC products and messenger RNA (mRNA) in tissue fragments obtained from two corticotropic adenomas, five nonpituitary tumors, and two normal human pituitaries. The POMC products were examined using a combination of gel exclusion chromatography and four different radioimmunoassays directed against gamma 3 melanocyte stimulating hormone (gamma 3MSH), ACTH, gamma-lipotropin (gamma LPH), and beta-endorphin. The POMCmRNA was detected and analyzed by dot and northern blot hybridization using a single-stranded genomic DNA probe corresponding to the coding region of the human POMC gene. Tissue concentrations of POMC products and mRNA showed parallel distributions. Immunoreactive gamma 3MSH and gamma LPH patterns revealed only 16-kD fragment- and gamma LPH-like peptides in normal and tumoral pituitaries; additional gamma 3MSH- and/or beta MSH-like peptides were found in all five nonpituitary tumors. A single POMCmRNA of approximately 1,200 bases (b) was detected in normal and tumoral pituitaries; a single identical POMCmRNA was also found in four nonpituitary tumors. A thymic carcinoid tumor, in addition to the 1,200-b POMCmRNA, contained equal amounts of a second larger POMCmRNA of approximately 1,450 b. It is concluded that POMC gene expression appears qualitatively unaltered in corticotropic adenomas. In nonpituitary tumors, in contrast, abnormal POMC processing is frequent; in addition, an extra POMCmRNA was detected in a thymic tumor with a greater length than the normal mRNA; the mechanisms and pathophysiological implications of these modifications remain to be elucidated.
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
December 1993,
The Journal of clinical investigation,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
March 1980,
The Journal of clinical endocrinology and metabolism,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
March 2006,
Molecular and cellular endocrinology,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
September 1988,
Molecular endocrinology (Baltimore, Md.),
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
July 2001,
The Journal of clinical endocrinology and metabolism,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
December 1994,
The Journal of clinical endocrinology and metabolism,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
June 2011,
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
January 2008,
Endocrine pathology,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
January 1998,
Endocrine pathology,
Y de Keyzer, and
X Bertagna, and
F Lenne, and
F Girard, and
J P Luton, and
A Kahn
September 2001,
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
